Flucloxacillin is one of 12 small molecule programs targeting Skin Infection. It is currently in Preclinical.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
12 competitors in Skin Infection
Keflex
Vancocin
Lotrimin
Cubicin
Omnicef
Tygacil
Betadine
Altabax
Acanya
Rocephin
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Sources